Araştırma Makalesi
BibTex RIS Kaynak Göster
Yıl 2017, Cilt: 3 Sayı: 4, 177 - 182, 28.12.2017

Öz

Kaynakça

  • 1. Blanchet PJ , Kivenko V.Drug-induced parkinsonism: diagnosis and management. Journal of Parkinsonism and Restless Legs Syndrome 2016:6 83–91.
  • 2. Ka¨gi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 2010;81:5–12.doi:10.1136/jnnp.2008.157370.
  • 3. Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J 2009;85:322–326.doi:10.1136/pgmj.2008.073312.
  • 4. Friedman JH, Trieschmann ME, Fernandez HH. Chap. 6: Drug induced parkinsonism. In: Factor SA, Lang AE, Weiner WJ, editors. Drug Induced Movement Disorders. 2nd ed. Madden, MA: Blackwell Publishing;2005:103–139.
  • 5. Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O, Montastruc JL. Drug- induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France. Mov Disord. 2011 Oct;26(12):2226-31. doi: 10.1002/mds.23828. Epub 2011 Jun 14.
  • 6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. Arlington, VA: American Psychiatric Association; 2013
  • 7. Hassin-Baer S, Sirota P, Korczyn AD, et al. Clinical characteristics of neuroleptic-induced parkinsonism. J Neural Transm (Vienna). 2001;108(11):1299–1308
  • 8. Mendelson g. pheniramine amynosalicylate overdosage: reversal delirium and choreiform movement with tacrine treatment.arch neurol. 1977.
  • 9. Kim HJ, Kang HJ, Han S-H. "Inhaled steroid induced hemichorea-hemiballism." Parkinsonism & Related Disorders 22 (2016): e134.
  • 10. Fann WE, Lake CR. Amantadine versus trihexyphenidyl in the treatment of neuroleptic- induced parkinsonism. Am J Psychiatry. 1976;133(8):940–943.

A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT

Yıl 2017, Cilt: 3 Sayı: 4, 177 - 182, 28.12.2017

Öz

İlaca
bağlı parkinsonizm, genellikle ileri yaşlarda, akut ya da subakut ortaya çıkan,
büyük oranda geri dönüşümlü klinik bir sendromdur. Ancak tanının gecikmesi
ve/veya etyolojik ajan kullanımının devamı halinde progresif ve ciddi bir seyir
gösterebilir. Yaygın olarak anti-psikotiklerle ilişkilendirilen sendroma birçok
farklı ajan da yol açabilmektedir.



Burada 26 yaşında alerjik reaksiyonu intramuskuler
feniramin hidrojen maleat+dexametazon enjeksiyonu ile tedavi edilen bir olgu
sunulmuştur. Enjeksiyondan 4-5 saat sonra kol ve bacaklarını hareket ettirmekte
zorlanma ve yürüme güçlüğü şikayetlerinin başladığı öğrenildi. Şikayetleri ıv
ve oral antikolnerjik tedavi ile üç hafta içinde geriledi. Dexametazon ve
feniramin kullanımına sekonder akut parkinsonizm olgumuz, literatürde bir
benzeri olmaması ve acil servis koşullarında oldukça sık kullanılan bir
kombinasyona bağlı gelişmesi nedeniyle paylaşılmaya değer görülmüştür.

Kaynakça

  • 1. Blanchet PJ , Kivenko V.Drug-induced parkinsonism: diagnosis and management. Journal of Parkinsonism and Restless Legs Syndrome 2016:6 83–91.
  • 2. Ka¨gi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 2010;81:5–12.doi:10.1136/jnnp.2008.157370.
  • 3. Thanvi B, Treadwell S. Drug induced parkinsonism: a common cause of parkinsonism in older people. Postgrad Med J 2009;85:322–326.doi:10.1136/pgmj.2008.073312.
  • 4. Friedman JH, Trieschmann ME, Fernandez HH. Chap. 6: Drug induced parkinsonism. In: Factor SA, Lang AE, Weiner WJ, editors. Drug Induced Movement Disorders. 2nd ed. Madden, MA: Blackwell Publishing;2005:103–139.
  • 5. Bondon-Guitton E, Perez-Lloret S, Bagheri H, Brefel C, Rascol O, Montastruc JL. Drug- induced parkinsonism: a review of 17 years' experience in a regional pharmacovigilance center in France. Mov Disord. 2011 Oct;26(12):2226-31. doi: 10.1002/mds.23828. Epub 2011 Jun 14.
  • 6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth ed. Arlington, VA: American Psychiatric Association; 2013
  • 7. Hassin-Baer S, Sirota P, Korczyn AD, et al. Clinical characteristics of neuroleptic-induced parkinsonism. J Neural Transm (Vienna). 2001;108(11):1299–1308
  • 8. Mendelson g. pheniramine amynosalicylate overdosage: reversal delirium and choreiform movement with tacrine treatment.arch neurol. 1977.
  • 9. Kim HJ, Kang HJ, Han S-H. "Inhaled steroid induced hemichorea-hemiballism." Parkinsonism & Related Disorders 22 (2016): e134.
  • 10. Fann WE, Lake CR. Amantadine versus trihexyphenidyl in the treatment of neuroleptic- induced parkinsonism. Am J Psychiatry. 1976;133(8):940–943.
Toplam 10 adet kaynakça vardır.

Ayrıntılar

Konular Sağlık Kurumları Yönetimi
Bölüm Olgu Sunumu
Yazarlar

Saadet Sayan Bu kişi benim

Yayımlanma Tarihi 28 Aralık 2017
Gönderilme Tarihi 19 Eylül 2017
Kabul Tarihi 13 Aralık 2017
Yayımlandığı Sayı Yıl 2017 Cilt: 3 Sayı: 4

Kaynak Göster

APA Sayan, S. (2017). A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT. Journal of Human Rhythm, 3(4), 177-182.
AMA Sayan S. A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT. Journal of Human Rhythm. Aralık 2017;3(4):177-182.
Chicago Sayan, Saadet. “A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT”. Journal of Human Rhythm 3, sy. 4 (Aralık 2017): 177-82.
EndNote Sayan S (01 Aralık 2017) A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT. Journal of Human Rhythm 3 4 177–182.
IEEE S. Sayan, “A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT”, Journal of Human Rhythm, c. 3, sy. 4, ss. 177–182, 2017.
ISNAD Sayan, Saadet. “A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT”. Journal of Human Rhythm 3/4 (Aralık 2017), 177-182.
JAMA Sayan S. A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT. Journal of Human Rhythm. 2017;3:177–182.
MLA Sayan, Saadet. “A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT”. Journal of Human Rhythm, c. 3, sy. 4, 2017, ss. 177-82.
Vancouver Sayan S. A RARE CASE OF SECONDER PARKINSONISM CAUSED BY ANTIALLERGIC TREATMENT. Journal of Human Rhythm. 2017;3(4):177-82.